The Appendix Cancer Pseudomyxoma Peritonei (ACPMP) Research Foundation is pleased to announce the recipients of our 2021 research grant cycle. Thank you as always to our incredible, dedicated supporters, fundraisers, and donors for making these grants happen. And thank you to the many researchers who applied to our research grant program and to all of the scientific community engaged in...

              Congratulations to Dr. John Paul Shen at MD Anderson for being a recipient of the 2022 ASCO Conquer Cancer Foundation Career Development Award (CDA). This CDA comes with a 3-year, $200,000 research grant focused on appendix cancer. The ACPMP Research Foundation is pleased to have previously provided Dr. Shen with a letter of...

This week is Adolescent and Young Adult (AYA) Cancer Awareness week, April 4th - April 8th. Adolescent and Young Adult Cancer Awareness Week was created to help shine a light on the unique challenges that AYA cancer survivors face each day. The Appendix Cancer Pseudomyxoma Peritonei (ACPMP) Research Foundation would like to share some facts and resources to educate and...

ACPMP Executive Director, Deborah Shelton, has over 25 years of experience providing regulatory advice to a diverse group of stakeholders navigating the complex landscape of scientific and clinical research directed at the development of treatments for cancer and a wide range of other conditions, with a particular focus on rare diseases. In research funded with grant support from the ACPMP Research...

Please find below a Letter to the Editor written by Laura A. Lambert, MD, FACS, FSSO, on behalf of ACPMP’s Medical Advisory Board for the Appendix Cancer Pseudomyxoma Peritonei (ACPMP) Research Foundation. This letter was prompted by concerns raised to the organization by patients regarding the review article recently published in JAMA, titled “Diagnosis and Management of Acute Appendicitis in Adults”. Specifically, ACPMP patients...

We write today to share with you that Karolyn Lewandowski, ACPMP's Chief Operating Officer and General Counsel, is transitioning from her role with ACPMP after serving our community for nearly 14 years. Karolyn began volunteering for the ACPMP Research Foundation upon the organization’s formation in 2008 following her husband’s diagnosis of appendix cancer and pseudomyxoma peritonei (PMP) in late 2007....

Thank you to those of you who have supported the Appendix Cancer Pseudomyxoma Peritonei (ACPMP) Research Foundation throughout the year! We hope 2022 brings you good health, happiness, and the possibility of seeing you in person. At ACPMP, we believe it's always the right time to come together and support the greater good. We appreciate our amazing community doing just that:...

ACPMP Executive Director, Deborah Shelton, has over 20 years of experience providing legal counsel to clients navigating the complex regulations governing the testing and commercialization of FDA-regulated products, with a particular focus on pharmaceuticals and medical devices. Periodically provides insight on research topics of interest to our patient community. The Unfolding Promise Of cTDNA There are many promising scientific developments...

Dr. Andreana Holowatyj, Assistant Professor of Medicine at Vanderbilt University, is studying the impact of cancer, including appendix cancer, on reproductive health. She has a brief, confidential online survey (called the REACT Study). Dr. Holowatyj is a frequent collaborator with the ACPMP Research Foundation, and has served as a guest presenter for us --talking about the appendix cancer burden among adults...

The Appendix Cancer Survivorship Symposium was held on October 15, 2021 and was hosted by The Appendix Cancer Pseudomyxoma Peritonei (ACPMP) Research Foundation, Atrium Health Wake Forest Baptist, University of Chicago Medicine and University of Utah Huntsman Cancer Institute. This event was held virtually via Zoom and was free and open to all! We had over 400 registrations from 25...